A Look At Skyward Specialty Insurance Group (SKWD) Valuation After Strong Q1 Earnings And Apollo Acquisition Impact

Skyward Specialty Insurance Group (SKWD) has drawn fresh attention after first quarter 2026 earnings showed revenue of US$475.87 million and net income of US$49.73 million. The results reflect contributions from the Apollo acquisition.

See our latest analysis for Skyward Specialty Insurance Group.

At a share price of US$46.69, the stock has seen a 6.99% 7 day share price return and a 2.59% 1 day share price return around the earnings release, while the 1 year total shareholder return has declined 21.86% and the 3 year total shareholder return is up 89.33%, pointing to long term gains but softer recent momentum.

If this insurance update has you thinking about where else growth and re rating potential could emerge, it may be worth scanning 19 top founder-led companies

With the stock down 21.86% over the past year yet still up 89.33% over three years, investors now face a key question: is Skyward Specialty undervalued after the pullback, or is the market already pricing in future growth?

Most Popular Narrative: 26.5% Undervalued

Skyward Specialty Insurance Group's fair value narrative sits at US$63.50 versus a last close of US$46.69. This sets up a clear valuation gap for investors to weigh.

The company's focus on complex, underserved markets such as small group medical stop loss, innovative property captives, and niche aviation risk enables continued high retention, high margin growth insulated from softening rates in more commoditized lines, underpinning strong earnings quality and sustainable margin expansion.

Read the complete narrative.

Want to see what could justify that higher fair value? The narrative leans on compounding revenue growth, firmer margins, and a future earnings multiple that assumes investors keep paying up for this specialty profile.

Result: Fair Value of $63.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this upside story can be challenged if competition compresses pricing in key lines, or if the concentrated MGA and program manager partnerships fail to deliver as expected.

Find out about the key risks to this Skyward Specialty Insurance Group narrative.

Next Steps

Given the mixed sentiment around valuation and recent returns, it may be useful to review the underlying numbers yourself and decide where you stand. Take a closer look at the 4 key rewards

Looking for more investment ideas?

If you stop with one stock, you risk missing other opportunities across quality, income, and growth, so take a few minutes and widen your watchlist today.

• Strengthen your core holdings by focusing on resilient companies with robust finances through the solid balance sheet and fundamentals stocks screener (44 results).
• Target potential mispricings by scanning the market for quality stocks trading below their estimated worth using the 49 high quality undervalued stocks.
• Add steady income potential to your portfolio by zeroing in on companies with higher yields through the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com